awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51547548-0D942C63-256B-4ED1-87B0-55D628B78CC7
Q51547548-0D942C63-256B-4ED1-87B0-55D628B78CC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51547548-0D942C63-256B-4ED1-87B0-55D628B78CC7
Limits of 80%-125% for AUC and 70%-143% for Cmax. What is the impact on bioequivalence studies?
P1433
Q51547548-0D942C63-256B-4ED1-87B0-55D628B78CC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51547548-0D942C63-256B-4ED1-87B0-55D628B78CC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ba3a35199d3bdeb18af221ed749b843a494bd79e
P1433
International Journal of Clinical Pharmacology and Therapeutics